NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

Happy 2014 everyone! 2013 was not a breakout year for NWBO, but the stock price was up on the year. Given that there was dilution and no trial results, that's a good year for a small biotech.

I'll no doubt regret making any guesses for 2014. Predictions never come true the way I think they will, but here goes:

Stock price closes at 12.13 on 12/31/2014. Topline phase III results won't come until Q1 2015, maybe even Q2. So a $12+ stock price would be very, very good. And more dilution in April and October.

I think DCVax-Direct will have good results, but not instantly a game-changer. Phase III will need to be completed. But the good early results - I can't remember what I guessed before - but I'll say 30% have tumor shrinkage and 40% have stable disease - help push the stock over $10.

I'll update my guesses one year from today!!